View All Key Stats
NVAX Key Stats
| Income Statement | |
| Revenue (TTM) | 35.15M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.61 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -186.27M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -480.2% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 591.60M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 13.60 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -66.22M |
| Return on Equity (TTM) | Upgrade |
View All NVAX News
NVAX News
-
WireHeadlineTime (ET)
-
MT Newswires06/14 16:00
-
MT Newswires06/14 13:50
-
MT Newswires06/14 08:43
-
SA Breaking News06/14 08:12
-
MT Newswires06/14 06:14
-
Globe Newswire06/13 17:05
-
SA Breaking News05/22 09:49
-
Yahoo05/22 07:00
-
Yahoo05/17 06:33
-
MT Newswires05/16 13:21
View All Events
NVAX Events
| Date | Type | Description |
|---|---|---|
| 08/08/2018 | Misc | Novavax Inc Second Quarter Earnings Conference Call in 2018 |
| 08/08/2018 | Earnings | Novavax Inc Second Quarter Earnings Results in 2018 |
| 06/14/2018 | Misc | Novavax Inc Annual General Meeting in 2017 |
| 05/09/2018 16:30 EDT | Misc | Novavax Inc First Quarter Earnings Conference Call in 2018 |
| 05/09/2018 | Earnings | Novavax Inc First Quarter Earnings in 2018 Release |
| 03/14/2018 17:00 EDT | Misc | Novavax Inc Fourth Quarter Earnings Conference Call in 2017 |
| 03/14/2018 | Earnings | Novavax Inc Fourth Quarter Earnings Results in 2017 |
| 11/07/2017 16:30 EDT | Misc | Novavax Inc Third Quarter Earnings Conference Call in 2017 |
| 11/07/2017 | Earnings | Novavax Inc Third Quarter Earnings in 2017 Release |
| 08/08/2017 16:30 EDT | Misc | Novavax Inc First Quarter Earnings Conference Call in 2017 |
NVAX Fundamentals
Income Statement View Statement
NVAX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NVAX One Page Reports
- One Page Report Download
NVAX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 1.56 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.novavax.com
- Investor Relations URL: http://ir.novavax.com/phoenix.zhtml?c=71178&p=irol-irhome
- HQ State/Province: Maryland
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Aug. 08, 2018
- Last Earnings Release: May. 09, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
NVAX Excel Add-In Codes
- Name: =YCI("NVAX","name")
- Description: =YCI("NVAX","description")
- Sector: =YCI("NVAX","sector")
- Industry: =YCI("NVAX","industry")
- Est. Current Fiscal Year End: =YCI("NVAX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NVAX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVAX Tweets Stocktwits
Advertisement
